Synapse Medicine adds $28M for its platform supporting proper medication use
European venture firm Korelya Capital led the funding round, Synapse's third in as many years, bringing the total amount the startup has raised to $40 million.
European venture firm Korelya Capital led the funding round, Synapse's third in as many years, bringing the total amount the startup has raised to $40 million.
ActualMeds graduated from New York Digital Health accelerator‘s inaugural class last year with a goal of making it easier for patients with a high risk of readmission to manage their medication. More than one year later, it’s raised two-thirds of the company’s first equity round. It plans to use the $5 million it’s seeking in […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In the past, the only thing a patient was sure to get after a hospital stay was a bill. But as Medicare cracks down on high readmission rates, hospitals are dispatching nurses, transportation, culturally specific diet tips, free medications and even ba...